Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 933-779-9 | CAS number: -
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Description of key information
OECD 429 (LLNA): Skin Sensitiser 1B (H317: May cause an allergic skin reaction)
Key value for chemical safety assessment
Skin sensitisation
Link to relevant study records
- Endpoint:
- skin sensitisation: in vivo (LLNA)
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 2019-02-07 to 2019-04-09
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 429 (Skin Sensitisation: Local Lymph Node Assay)
- Version / remarks:
- 22 July 2010
- Deviations:
- yes
- Remarks:
- Deviations were considered not to adversely affect the results or integrity of the study.
- GLP compliance:
- yes (incl. QA statement)
- Type of study:
- mouse local lymph node assay (LLNA)
- Specific details on test material used for the study:
- SOURCE OF TEST MATERIAL
- Source and lot/batch No.of test material:
Emerald Kalama Chemical Ltd. (United Kingdom); Lot No. A170524D
- Expiration date of the lot/batch: 2019-06-06
- Purity test date: 2018-02-07
STABILITY AND STORAGE CONDITIONS OF TEST MATERIAL
- Storage condition of test material: Room temperature (15-25oC, ≤70 RH%), under inert gas, protected from humidity (tight closed container)
- Stability under test conditions:Not specified
- Solubility and stability of the test substance in the solvent/vehicle: Not specified
TREATMENT OF TEST MATERIAL PRIOR TO TESTING
- Treatment of test material prior to testing: The test item was weighed and formulations prepared daily on a weight:volume basis (as % (w/v)) in the Pharmacy of Citoxlab Hungary Ltd. Analytical determination of the test item concentration, stability and homogeneity was not performed because of the character and the short period of study.
FORM AS APPLIED IN THE TEST (if different from that of starting material): Colorless liquid - Species:
- mouse
- Strain:
- CBA/Ca
- Remarks:
- CaOlaHsd mice
- Sex:
- female
- Details on test animals and environmental conditions:
- TEST ANIMALS
- Source: Envigo (San Pietro al Natisone (UD), Zona Industriale Azzida, 57, 33049 Italy)
- Females (if applicable) nulliparous and non-pregnant: yes
- Microbiological status of animals, when known: Only healthy animals were used for the study. Health status was certified by the veterinarian.
- Age at study initiation: 12 weeks old (age-matched, within one week)
- Weight at study initiation: 21.3 – 23.9 grams (The weight variation in animals in the study did not exceed ± 20% of the mean weight.)
- Housing: Group caging / mice were provided with glass tunnel-tubes (Type II polypropylene / polycarbonate cages)
- Diet (e.g. ad libitum): ssniff® SM Rat/Mouse – Breeding and Maintenance, 15 mm, autoclavable “Complete feed for Rats and Mice – Breeding and Maintenance” (Batch number: 639 38520, Expiry date: April 2019 produced by ssniff Spezialdiäten GmbH (Ferdinand-Gabriel-Weg 16, D-59494 Soest, Germany), and Gel diet Transport (Batch Number: 60182980010101, Expiry date: 25 October 2019, Scientific Animal Food & Engineering, Route de Saint Bris, 89290 Augy, France) ad libitum.
- Water (e.g. ad libitum): tap water from the municipal supply from 500 mL bottles, ad libitum.
- Acclimation period: 50 days
- Indication of any skin lesions: Not specified but only healthy animals were used for the study. Health status was certified by the veterinarian.
Note: In the Preliminary Experiment, mice of 10 weeks of age (18.2-18.9 grams) were used.
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 18.6 – 25.9°C
- Humidity (%): 22 - 74 %
- Air changes (per hr): 15-20 air exchanges/hour
- Photoperiod (hrs dark / hrs light): 12 hours daily, from 6.00 a.m. to 6.00 p.m.
- IN-LIFE DATES: Preliminary Experiment (From: 2019-01-23 To: 2019-01-28); Experiment (From: 2019-02-07 to 2019-02-13) - Vehicle:
- acetone/olive oil (4:1 v/v)
- Concentration:
- Test material formulations at 50%, 25% and 10% (w/v) in AOO (acetone/olive oil (4:1 v/v))
- No. of animals per dose:
- 4 per dose
- Details on study design:
- PRE-SCREEN TESTS:
- Compound solubility: The solubility of the test material was examined in a short Preliminary Compatibility Test. The following standard OECD vehicles was assessed: AOO (acetone:olive oil 4:1 (v:v) mixture). The best vehicle taking into account the test material characteristics and the requirements of the relevant OECD guideline was considered to be AOO. The highest achievable concentration based on the regulatory requirements of OECD 429 and the physical characteristics of the test material was 100% (undiluted). The formulations at 50%, 25% and 10% (w/v) in AOO were also suitable for treatment. The formulations appeared to be solutions by visual examination.
The test material was weighed and formulations prepared daily on a weight:volume basis (as % (w/v)) in the Pharmacy of Citoxlab Hungary Ltd.
Analytical determination of the test item concentration, stability and homogeneity was not performed because of the character and the short period of study.
- Irritation: In the Preliminary Irritation / Toxicity Test, all mice were observed daily for any local irritation at the application site.
- Systemic toxicity: In the Preliminary Irritation / Toxicity Test, all mice were observed daily for any clinical signs of systemic toxicity.
- Ear thickness measurements: Ear thickness was measured using a thickness gauge on Day 1 (pre-dose), Day 3 (approximately 48 hours after the first dose) and Day 6. Additional quantification of the ear thickness was performed by ear punch weight determination after the euthanasia of the experimental animals.
- Erythema scores: Both ears of each mouse were observed for erythema and scored using the criteria detailed below:
Erythema Scoring
Observation Score
No erythema 0
Very slight erythema (barely perceptible) 1
Well-defined erythema 2
Moderate to severe erythema 3
Severe erythema (beef redness) to eschar formation preventing grading of erythema 4
Note: Excessive local skin irritation is indicated by an erythema score ≥ 3 and/or an increase in ear thickness of ≥ 25 % on any day of measurement.
MAIN STUDY
ANIMAL ASSIGNMENT AND TREATMENT
A unique number written on the tail with a permanent marker identified each animal. The animal number was assigned on the basis of Citoxlab Hungary Ltd.’s master file. The cages were marked with identity cards with information including study code, cage number, and dose group, sex and individual animal number. The animals were randomised and allocated to the experimental groups. The randomisation was checked by computer software using the body weight to verify the homogeneity and variability between the groups.
- Name of test method: Local Lymph Node Assay (OECD 429)
- Criteria used to consider a positive response: The test material is regarded as a sensitizer if both of the following criteria are fulfilled:
- That exposure to at least one concentration of the test material resulted in an incorporation of 3HTdR at least 3-fold or greater than recorded in control mice, as indicated by the stimulation index.
- The data are compatible with a conventional dose response, although allowance must be made (especially at high topical concentrations) for either local toxicity or immunological suppression.
TREATMENT PREPARATION AND ADMINISTRATION:
Test material formulations at 50%, 25% and 10% (w/v) in AOO (acetone:olive oil 4:1 (v:v) mixture) were observed to be suitable for treatment. The formulations appeared to be solutions by visual examination.
The test material was weighed and formulations prepared daily on a weight:volume basis (as % (w/v)) in the Pharmacy of Citoxlab Hungary Ltd.
The Preliminary Irritation/Toxicity Test, was started according to the Study Plan on CBA/CaOlaHsd mice using two doses (2 animals/dose) at test material concentrations of 100% (undiluted)and 50% (w/v) in AOO. The preliminary experiments were conducted in a similar experimental manner to the main study, but it was terminated on Day 6 and the radioactive proliferation assay was not performed.
The maximum concentration of test material in an acceptable vehicle was established according to OECD guideline 429. Based on the observation of the solubility test, the maximum available concentration was 100% (undiluted).
Data from the preliminary study data indicated that the 100% (undiluted) dose group results were above the acceptable limit, and therefore, the 50% (w/v) dose level should be the High dose in the main study.
The experimental groups and dose levels for the main experiment are summarized in Table 1.
During the study, animals were topically dosed with 25 µL of the appropriate formulation using a pipette on the dorsal surface of each ear. Each animal was dosed once a day for three consecutive days (Days 1, 2 and 3). There was no treatment on Days 4, 5 and 6. - Positive control substance(s):
- hexyl cinnamic aldehyde (CAS No 101-86-0)
- Statistics:
- Number of radioactive disintegrations per minute (DPM) were measured for each pooled group of nodes. The measured DPM values were corrected with the background DPM value (“DPM”). The average of the two measured DPM values of 5 % (w/v) TCA solutions was used as background DPM value. The results were expressed as “DPN” (DPM divided by the number of lymph nodes) following the industry standard for data presentation.
Stimulation index (SI = DPN value of a treated group divided by the DPN value of the negative control group) for each treatment group was also calculated. - Positive control results:
- The result of the positive control substance α-Hexylcinnamaldehyde (HCA) dissolved in the same vehicle was used to demonstrate the appropriate performance of the assay. The positive control substance was examined at a concentration of 25% in the relevant vehicle (AOO) using CBA/CaOlaHsd mice.
No mortality cutaneous reactions or signs of toxicity were observed for the positive control substance in the study. A lymphoproliferative response in line with historical positive control data (stimulation index value of 4.1 was noted for HCA in the main experiment). This value was considered to confirm the appropriate performance of the assay.
Furthermore, the DPN values observed for the vehicle and positive control substance in this experiment were within the historical control range. Each treated and control group included 4 animals. - Key result
- Parameter:
- SI
- Value:
- 1
- Variability:
- DPN = 530.9
- Test group / Remarks:
- Negative Control (AOO)
- Key result
- Parameter:
- SI
- Value:
- 9
- Variability:
- DPN = 4791.8
- Test group / Remarks:
- Ocimene PQ 50% (w/v) in AOO
- Key result
- Parameter:
- SI
- Value:
- 9.1
- Variability:
- DPN = 4851.1
- Test group / Remarks:
- Ocimene PQ 25% (w/v) in AOO
- Key result
- Parameter:
- SI
- Value:
- 4.9
- Variability:
- DPN = 2599.1
- Test group / Remarks:
- Ocimene PQ 10 (w/v)% in AOO
- Key result
- Parameter:
- SI
- Value:
- 4.1
- Variability:
- DPN = 2151.9
- Test group / Remarks:
- Positive control (25% (w/v) HCA in AOO
- Cellular proliferation data / Observations:
- CELLULAR PROLIFERATION DATA
The appearance of the lymph nodes was normal in the negative control group. Larger than normal lymph nodes were observed in the 50% and 25% (w/v) dose groups. Normal lymph nodes were observed for 3 animals and slightly enlarged than normal was observed for one animal in the 10% (w/v) dose group. Larger than normal lymph nodes were observed in the positive control group. The results of the proliferation assay are summarized in Table 3.
DETAILS ON STIMULATION INDEX CALCULATION
Number of radioactive disintegrations per minute (DPM) were measured for each pooled group of nodes. The measured DPM values were corrected with the background DPM value (“DPM”). The average of the two measured DPM values of 5 % (w/v) TCA solutions was used as background DPM value. The results were expressed as “DPN” (DPM divided by the number of lymph nodes) following the industry standard for data presentation.
Stimulation index (SI = DPN value of a treated group divided by the DPN value of the negative control group) for each treatment group was also calculated.
The stimulation index values were 9.0, 9.1 and 4.9 at concentrations of 50% (w/v), 25% (w/v) and 10% (w/v), respectively. A lymphoproliferative response in line with historical positive control data (stimulation index value of 4.1 was noted for HCA in the main experiment).
EC3 CALCULATION
The extrapolated EC3 value of Ocimene PQ [Reaction mass of dipentene and (Z)-3,7-dimethylocta-1,3,6,-triene] was determined to be 6.6% (w/v).
CLINICAL OBSERVATIONS:
There was no evidence of mortality or systemic toxicity observed during the main study. No evidence of test material residue on the ears of animals was observed and there were no indications of any irritancy at the site of application.
BODY WEIGHTS
Marked body weight loss (≥5%) was observed for one animal in the negative control group, for two animals in the 50% (w/v) and 10% (w/v) dose groups, and in one animal of the 25% (w/v) dose group. However, the mean body weight changes of these groups were within the acceptable range and therefore considered as individual variability.
No treatment-related effects were observed on the mean body weight changes in the main study. Individual and mean body weights are summarised in Table 2.
Ear Thickness Measurement
The ear thickness values and the biopsy weights were within the acceptable range for all the animals in the 25% and 10% (w/v) test item treated groups and in the negative control group. The detected ear thickness values indicated local irritation (≥ 25 %) for one animal (only right ear) of the 50% (w/v) dose group on Day 6 and for one animal (only right ear) of the 25% (w/v) dose group on Day 3. Furthermore, the detected ear thickness values indicated local irritation (≥ 25 %) for one animal (only left ear) of the positive control group on Day 3 and Day 6 and for another animal (only right ear) of the positive control group on Day 3. However, the revealing ear punch weights were within the acceptable range in each case. These facts were considered not to adversely affect the results or integrity of the study. - Interpretation of results:
- Category 1B (indication of skin sensitising potential) based on GHS criteria
- Conclusions:
- Under the conditions of the present assay, the test material [Reaction mass of dipentene and (Z)-3,7-dimethylocta-1,3,6,-triene], tested in a suitable vehicle, was shown to have a sensitisation potential (sensitizer) in the Local Lymph Node Assay. The extrapolated EC3 value of the test material is 6.6% (w/v). Based on the results observed, Reaction mass of dipentene and (Z)-3,7-dimethylocta-1,3,6,-triene meets the criteria to be classified as a skin sensitiser Category 1B (H317: May cause an allergic skin reaction) under EU Regulation (EC) No 1272/2008 (CLP) and GHS (rev. 7) 2017.
- Executive summary:
A key OECD Guideline 429 study was conducted to determine the skin sensitisation potential of the test material (Reaction mass of dipentene and (Z)-3,7-dimethylocta-1,3,6,-triene) following dermal exposure in CBA/CaOlaHsd mice.
A Preliminary Compatibility Test was undertaken and the results of the same along with the test material characteristics, its usage, and on the recommendations of the OECD Guideline, the best vehicle was determined to be AOO (acetone:olive oil 4:1 (v:v) mixture). The highest achievable concentration was 100% (undiluted) with formulations at 50% (w/v), 25% (w/v) and 10% (w/v) in AOO also suitable for treatment.
A Preliminary Irritation/Toxicity Test was performed in CBA/CaOlaHsd mice using two doses (2 animals/dose), 100% (undiluted) and 50% (w/v) in AOO. Based on the observations recorded in the preliminary test, the 50% (w/v) dose was selected as top dose for the main test.
In the main assay, twenty female CBA/CaOlaHsd mice were allocated to five groups of four animals each:
- three groups received the test material (formulated in AOO) at 50% (w/v), 25% (w/v) and 10% (w/v) concentrations,
- the negative control group received the vehicle (AOO) only,
- the positive control group received 25 % (w/v) α-Hexylcinnamaldehyde HCA (dissolved in AOO).
Test material formulations were applied to the dorsal surface of ears of experimental animals (25 µL/ear) for three consecutive days (Days 1, 2 and 3). There was no treatment on Days 4, 5 and 6. The cell proliferation in the local lymph nodes was assessed by measuring the incorporation of tritiated methyl thymidine (3HTdR) and the values obtained were used to calculate stimulation indices (SI) in comparison with the control group.
There was no evidence of mortality or systemic toxicity observed during the main study. No evidence of test material residue on the ears of animals was observed and there were no indications of any irritancy at the site of application. No treatment-related effects were observed on the mean body weight changes in the main study. The stimulation index values were 9.0, 9.1 and 4.9 at concentrations of 50% (w/v), 25% (w/v) and 10% (w/v), respectively.
The result of the positive control substance (HCA) dissolved in the same vehicle was used to demonstrate the appropriate performance of the assay. A lymphoproliferative response (SI = 4.1) in harmony with historical control data was noted for the positive control chemical, this result confirmed the validity of the assay.
In conclusion, under the conditions of the present assay, the test material [Reaction mass of dipentene and (Z)-3,7-dimethylocta-1,3,6,-triene], tested in a suitable vehicle, was shown to have a sensitisation potential (sensitizer) in the Local Lymph Node Assay. The extrapolated EC3 value of the test material is 6.6% (w/v). Based on the results observed, Reaction mass of dipentene and (Z)-3,7-dimethylocta-1,3,6,-triene meets the criteria to be classified as a skin sensitiser Category 1B (H317: May cause an allergic skin reaction) under EU Regulation (EC) No 1272/2008 (CLP) and GHS (rev. 7) 2017.
Reference
Table 2. Individual Body Weights for all Animals with Group Means |
|||||
Animal Number |
Identity Number |
Test Group Name |
Initial Body Weight (g) |
Terminal Body Weight* (g) |
Change# (%) |
7496 |
1 |
Negative (vehicle) control |
23.7 |
21.4 |
-9.7 |
7504 |
2 |
AOO |
22.1 |
23.3 |
5.4 |
7500 |
3 |
|
22.4 |
22.8 |
1.8 |
7499 |
4 |
|
21.3 |
20.3 |
-4.7 |
|
|
Mean |
22.4 |
22.0 |
-1.8 |
7508 |
5 |
Ocimene PQ |
23.6 |
21.8 |
-7.6 |
7505 |
6 |
50 (w/v)% in AOO |
22.5 |
22.8 |
1.3 |
7514 |
7 |
|
21.6 |
20.4 |
-5.6 |
7495 |
8 |
|
21.5 |
21.7 |
0.9 |
|
|
Mean |
22.3 |
21.7 |
-2.7 |
7512 |
9 |
Ocimene PQ |
23.4 |
21.6 |
-7.7 |
7509 |
10 |
25 (w/v)% in AOO |
22.5 |
23.5 |
4.4 |
7503 |
11 |
|
21.8 |
22.7 |
4.1 |
7513 |
12 |
|
21.3 |
21.6 |
1.4 |
|
|
Mean |
22.3 |
22.4 |
0.6 |
7498 |
13 |
Ocimene PQ |
23.1 |
22.1 |
-4.3 |
7502 |
14 |
10 (w/v)% in AOO |
23.1 |
20.6 |
-10.8 |
7510 |
15 |
|
22.4 |
21.1 |
-5.8 |
7507 |
16 |
|
21.3 |
21.9 |
2.8 |
|
|
Mean |
22.5 |
21.4 |
-4.5 |
7501 |
17 |
Positive control |
23.9 |
23.5 |
-1.7 |
7511 |
18 |
25 (w/v) % HCA |
22.2 |
22.2 |
0.0 |
7497 |
19 |
in AOO |
21.3 |
20.8 |
-2.3 |
7506 |
20 |
|
21.6 |
22.0 |
1.9 |
|
|
Mean |
22.3 |
22.1 |
-0.5 |
Notes:
*: Terminal body weights were measured on Day 6.
#: = (Terminal Body Weight – Initial Body Weight) / Initial Body Weight x 100
Table 3. DPM. DPN and Stimulation Index Values for all Groups |
|||||
Test Group Name |
Measured DPM / group |
DPM |
Number |
DPN |
Stimulation Index |
Background (5% (w/v) TCA) |
34 |
- |
- |
- |
- |
Negative control (AOO) |
4280 |
4247.0 |
8 |
530.9 |
1.0 |
Ocimene PQ 50% (w/v) in AOO |
38367 |
38334.0 |
8 |
4791.8 |
9.0 |
Ocimene PQ 25% (w/v) in AOO |
38842 |
38809.0 |
8 |
4851.1 |
9.1 |
Ocimene PQ 10 (w/v)% in AOO |
20826 |
20793.0 |
8 |
2599.1 |
4.9 |
Positive control (25% (w/v) HCA |
17248 |
17215.0 |
8 |
2151.9 |
4.1 |
Table 4. Historical Control Data of the Positive and Negative Controls for CBA/CaOlaHsdmice(2014-2018)
|
Vehicles |
|||||
|
Acetone : Olive oil 4:1 (AOO) |
1% Pluronic PE9200 in water (1%Plu) |
||||
|
DPN values |
SI value |
DPN values |
SI value |
||
|
Control |
HCA 25% |
HCA 25% |
Control |
HCA 25% |
HCA 25% |
Average |
472.7 |
3851.3 |
9.0 |
198.7 |
1988.1 |
11.2 |
Range:min |
35.8 |
890.3 |
3.3 |
23.0 |
154.0 |
3.0 |
max |
1990.1 |
10336.0 |
20.2 |
680.8 |
6755.8 |
33.6 |
Number of cases |
92 |
88 |
86 |
234 |
226 |
218 |
|
Vehicles |
|||||
|
N,N-Dimethylformamide (DMF) |
Dimethyl sulfoxide (DMSO) |
||||
|
DPN values |
SI value |
DPN values |
SI value |
||
|
Control |
HCA 25% |
HCA 25% |
Control |
HCA 25% |
HCA 25% |
Average |
256.1 |
2738.9 |
11.3 |
466.0 |
3014.4 |
7.2 |
Range:min |
62.0 |
1201.3 |
4.9 |
218.3 |
1461.3 |
3.1 |
max |
649.6 |
5817.9 |
21.3 |
934.6 |
4877.5 |
14.5 |
Number of cases |
68 |
68 |
68 |
22 |
22 |
21 |
|
Vehicles |
|||||
|
Propylene glycol (PG) |
Methyl ethyl ketone (MEK) |
||||
|
DPN values |
SI value |
DPN values |
SI value |
||
|
Control |
HCA 25% |
HCA 25% |
Control |
HCA 25% |
HCA 25% |
Average |
245.1 |
2278.6 |
9.4 |
264.5 |
4129.5 |
16.9 |
Range:min |
63.3 |
817.3 |
5.8 |
80.5 |
1562.5 |
8.8 |
max |
506.0 |
4978.0 |
14.4 |
516.2 |
8682.5 |
36.3 |
Number of cases |
18 |
18 |
18 |
18 |
19 |
19 |
HCA 25% = alpha-Hexylcinnamaldehyde 25% (w/v)
SI (Stimulation Index) = DPN of a treated group divided by DPN of the appropriate control group.
DPN (Disintegrations Per Node) = DPM (Disintegrations Per Minute) divided by the number of lymph nodes.
In case of individual approach, SI values were calculated from the mean DPN values of the group.
Endpoint conclusion
- Endpoint conclusion:
- adverse effect observed (sensitising)
- Additional information:
A key OECD Guideline 429 study was conducted to determine the skin sensitisation potential of the test material (Reaction mass of dipentene and (Z)-3,7-dimethylocta-1,3,6,-triene) following dermal exposure in CBA/CaOlaHsd mice.
A Preliminary Compatibility Test was undertaken and the results of the same along with the test material characteristics, its usage, and on the recommendations of the OECD Guideline, the best vehicle was determined to be AOO (acetone:olive oil 4:1 (v:v) mixture). The highest achievable concentration was 100% (undiluted) with formulations at 50% (w/v), 25% (w/v) and 10% (w/v) in AOO also suitable for treatment.
A Preliminary Irritation/Toxicity Test was performed in CBA/CaOlaHsd mice using two doses (2 animals/dose), 100% (undiluted) and 50% (w/v) in AOO. Based on the observations recorded in the preliminary test, the 50% (w/v) dose was selected as top dose for the main test.
In the main assay, twenty female CBA/CaOlaHsd mice were allocated to five groups of four animals each:
- three groups received the test material (formulated in AOO) at 50% (w/v), 25% (w/v) and 10% (w/v) concentrations,
- the negative control group received the vehicle (AOO) only,
- the positive control group received 25 % (w/v) α-Hexylcinnamaldehyde HCA (dissolved in AOO).
Test material formulations were applied to the dorsal surface of ears of experimental animals (25 µL/ear) for three consecutive days (Days 1, 2 and 3). There was no treatment on Days 4, 5 and 6. The cell proliferation in the local lymph nodes was assessed by measuring the incorporation of tritiated methyl thymidine (3HTdR) and the values obtained were used to calculate stimulation indices (SI) in comparison with the control group.
There was no evidence of mortality or systemic toxicity observed during the main study. No evidence of test material residue on the ears of animals was observed and there were no indications of any irritancy at the site of application. No treatment-related effects were observed on the mean body weight changes in the main study. The stimulation index values were 9.0, 9.1 and 4.9 at concentrations of 50% (w/v), 25% (w/v) and 10% (w/v), respectively.
The result of the positive control substance (HCA) dissolved in the same vehicle was used to demonstrate the appropriate performance of the assay. A lymphoproliferative response (SI = 4.1) in harmony with historical control data was noted for the positive control chemical, this result confirmed the validity of the assay.
In conclusion, under the conditions of the present assay, the test material [Reaction mass of dipentene and (Z)-3,7-dimethylocta-1,3,6,-triene], tested in a suitable vehicle, was shown to have a sensitisation potential (sensitizer) in the Local Lymph Node Assay. The extrapolated EC3 value of the test material is 6.6% (w/v). Based on the results observed, Reaction mass of dipentene and (Z)-3,7-dimethylocta-1,3,6,-triene meets the criteria to be classified as a skin sensitiser Category 1B (H317: May cause anallergic skin reaction) under EU Regulation (EC) No 1272/2008 (CLP) and GHS (rev. 7) 2017.
Respiratory sensitisation
Endpoint conclusion
- Endpoint conclusion:
- no study available
Justification for classification or non-classification
Reaction mass of dipentene and (Z)-3,7-dimethylocta-1,3,6,-triene meets the criteria to be classified as a Category 1B skin sensitiser (H317: May cause an allergic skin reaction) under EU Regulation (EC) No 1272/2008 (CLP) and GHS (rev. 7) 2017.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.